Skip to main content
SpringerLink
Log in

Fracture case definition will assist bisphosphonate review

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Tet Sen H, Van Der Meulen MCH, Weinstein RS, Whyte M.Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research: [78 pages], 7 Sep 2010. Available from: URL: http://dx.doi.org/10.1002/jbmr.253

  2. FDA.FDA Statement on ASBMR report: possible increased risk of certain types of thigh bone fractures with long-term bisphosphonates use. Internet Document: [1 page], 14 Sep 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fracture case definition will assist bisphosphonate review. React. Wkly. 1320, 2 (2010). https://doi.org/10.2165/00128415-201013200-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013200-00004

Keywords

Search

Navigation